Researchers at the University of Michigan have identified a promising new drug compound for targeting one of the most aggressive types of breast cancer. The compound, currently called UM-164, goes after a kinase known to play a role in the growth and spread of triple-negative breast cancer. UM-164 blocks the kinase c-Src and inhibits another …
With Congress increasingly unable to resolve budget disputes, federal programs on automatic pilot are consuming ever larger amounts of government resources.
Mothers can play a key role for those struggling with the emotions and stress of living with cancer.
UCLA researchers led by Drs.